Salmonella meningitis in a young child from Pakistan: a case report

J Med Case Rep. 2023 Sep 14;17(1):390. doi: 10.1186/s13256-023-04128-0.

Abstract

Background: Salmonella meningitis is a rare but serious complication of Salmonella infection, primarily affecting infants, children, and immunocompromised individuals.

Case presentation: We present a case of a two-and-a-half-year-old Asian boy who developed Salmonella meningitis along with pneumonia and respiratory failure. Initially, he experienced symptoms of loose motions, fever, and irritability, which progressed to neck stiffness and brisk reflexes. Cerebrospinal fluid (CSF) analysis confirmed Salmonella typhi in the CSF. Due to the worsening condition, the patient was admitted to the intensive care unit, intubated, and switched to meropenem as the antibiotic of choice after an initial empiric therapy with ceftriaxone and vancomycin. With appropriate treatment, the patient showed significant improvement, including resolution of fever and respiratory symptoms.

Conclusion: Management of Salmonella meningitis is often challenging primarily because of the fact that the empiric therapy for meningitis may not always provide coverage to the multi-drug resistant Salmonella species found in South Asia. Prompt administration of appropriate antibiotics based on sensitivity testing is crucial for successful management. This case emphasizes the importance of early recognition and effective management of this uncommon yet severe complication of Salmonella infection.

Keywords: Antibiotic resistance; Communicable diseases; Infection; Infectious disease; Meningitis; Salmonella.

Publication types

  • Case Reports

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Ceftriaxone / therapeutic use
  • Child
  • Child, Preschool
  • Fever
  • Humans
  • Infant
  • Male
  • Meningitis, Bacterial* / diagnosis
  • Meningitis, Bacterial* / drug therapy
  • Pakistan
  • Salmonella Infections* / diagnosis
  • Salmonella Infections* / drug therapy
  • Salmonella typhi

Substances

  • Ceftriaxone
  • Anti-Bacterial Agents